Drug Search Results
More Filters [+]

GLS-5700

Alternative Names: gls-5700, gls5700, gls 5700
Latest Update: 2023-01-01
Latest Update Note: PubMed Publication

Product Description

GLS-5700 is a synthetic DNA plasmid vaccine against the Zika virus. (Sourced from: https://clinicaltrials.gov/ct2/show/NCT02887482)

Mechanisms of Action: Vaccine

Novel Mechanism: No

Modality: Vaccine

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: GeneOne Life Science
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for GLS-5700

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 1: Dengue|Pregnancy Outcomes|Zika Virus Infection|Microcephaly

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Zika-001

P1

Completed

Zika Virus Infection|Dengue|Pregnancy Outcomes|Microcephaly

2017-11-01

70%

Zika-002

P1

Completed

Zika Virus Infection|Microcephaly|Dengue|Pregnancy Outcomes

2017-10-01

70%

Recent News Events